Recruiting NA INTERVENTIONAL 2-arm
NCT07146412
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
Sponsor: HudsonAlpha Institute for Biotechnology
Conditions
Alzheimer Blood Biomarkers Alzheimer Disease (AD) Cognitive Impairment Mild Cognitive Impairment (MCI)
Interventions
Multimodal Lifestyle Intervention
Updated 1 time since 2025 Last updated: Aug 22, 2025 Started: May 2, 2025 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Alzheimer Blood Biomarkers and Alzheimer Disease (AD), this trial is actively recruiting participants. The trial is conducted by HudsonAlpha Institute for Biotechnology and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- HudsonAlpha Institute for Biotechnology
Data source: HudsonAlpha Institute for Biotechnology
For direct contact, visit the study record on ClinicalTrials.gov .